Filter News

Texas Public Radio: UTSA Lab Developing New Treatment For Aneurysms

September 1, 2016

A professor with the University of Texas at San Antonio is trying to come up with a new way to treat a deadly health problem: abdominal aortic aneurysms. Read the full story at Texas Public Radio


The University of Texas System: UT Horizon Fund invests $150K to fund medical device that repairs blood vessels

September 1, 2016

The UT Horizon Fund recently invested $150,000 to fund Cardiovate, a San Antonio-based startup that is using technology from two University of Texas System institutions to commercialize a medical device to treat vascular diseases by repairing blood ves …


MedPage Today: Triple Combo Tx Durable for T2D

September 1, 2016

Starting newly-diagnosed diabetes patients on the triple combination of metformin/pioglitazone/exenatide upfront provided better glucose control with less hypoglycemia than a standard sequential regimen, 3-year follow-up from the EDICT trial showed. Re …


UTSA Today: UTSA alumna’s medical device receives UT System investment

September 1, 2016

The UT Horizon Fund recently invested $150,000 to fund Cardiovate, a San Antonio-based startup that is using technology from two University of Texas System institutions to commercialize a medical device to treat vascular diseases by repairing blood ves …


Undark Magazine: Rethinking Prostate Cancer Treatments

September 1, 2016

In an outcome likely to raise broad questions about aggressive prostate cancer treatment, a randomized study of 1,643 British men found that, roughly 10 years after a prostate cancer diagnosis, the vast majority of participants had survived the cancer …


Laredo Morning Times: Veterans event will have on-site medical services, barbers, legal services

September 1, 2016

A first-time event, known as Stand Down for Homeless Veterans, was announced this week and plans are set to help address the needs of nearly 300 people in the four-hour service oriented session that begins at 9 a.m. and concludes at 1 p.m. on Sept. 20. …


Street Insider: Akebia Therapeutics (AKBA) Reports Publication of Strong Vadadustat Phase 2 Data in CKD-Related Anemia

September 1, 2016

Akebia Therapeutics, Inc. (Nasdaq: AKBA) announced the publication of positive results from a Phase 2b study of vadadustat, a once-daily oral HIF stabilizer, in development for the treatment of anemia related to chronic kidney disease (CKD). Read the f …


Neurons

National Pain Report: New directions for painkiller research

August 31, 2016

Health Science Center study suggests targeting opioid receptors outside the brain to reduce side effects.


Pharmacy

Experts available to discuss a societal scourge: overdose

August 31, 2016

Today, Aug. 31, 2016, is International Overdose Awareness Day. Several faculty members from the School of Medicine and School of Health Professions at the UT Health Science Center San Antonio are available to discuss this topic with the news media.


Zika research

Texas Public Radio: Scientists battling Zika in the lab

August 30, 2016

A lab at the Health Science Center conducting important research into the Zika virus.


Filter news